LGALS3 and differentiated thyroid carcinoma: The same analysis was done for 507 papillary thyroid carcinomas, and genomic alterations were reported in only 2% of cases for gal-1, 2.4% for gal-3, 2.4% for gal-7, 6% for gal-8, and 6% for gal-9, mainly involving mRNA up-regulation [17] (Figure 2B).